# A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

> **NCT06803680** · PHASE1 · RECRUITING · sponsor: **BeiGene** · enrollment: 90 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** BGB-B455
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06803680
- **Lead sponsor:** BeiGene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-18
- **Primary completion:** 2027-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06803680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06803680, "A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06803680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*